PMID- 26363497
OWN - NLM
STAT- MEDLINE
DCOM- 20160804
LR  - 20181202
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 24
IP  - Pt B
DP  - 2015 Dec
TI  - Update on the efficacy of extracorporeal shockwave treatment for myofascial pain 
      syndrome and fibromyalgia.
PG  - 201-6
LID - S1743-9191(15)01195-4 [pii]
LID - 10.1016/j.ijsu.2015.08.083 [doi]
AB  - Chronic muscle pain syndrome is one of the main causes of musculoskeletal 
      pathologies requiring treatment. Many terms have been used in the past to 
      describe painful muscular syndromes in the absence of evident local nociception 
      such as myogelosis, muscle hardening, myalgia, muscular rheumatism, fibrositis or 
      myofascial trigger point with or without referred pain. If it persists over six 
      months or more, it often becomes therapy resistant and frequently results in 
      chronic generalized pain, characterized by a high degree of subjective suffering. 
      Myofascial pain syndrome (MPS) is defined as a series of sensory, motor, and 
      autonomic symptoms caused by a stiffness of the muscle, caused by hyperirritable 
      nodules in musculoskeletal fibers, known as myofascial trigger points (MTP), and 
      fascial constrictions. Fibromyalgia (FM) is a chronic condition that involves 
      both central and peripheral sensitization and for which no curative treatment is 
      available at the present time. Fibromyalgia shares some of the features of MPS, 
      such as hyperirritability. Many treatments options have been described for muscle 
      pain syndrome, with differing evidence of efficacy. Extracorporeal Shockwave 
      Treatment (ESWT) offers a new and promising treatment for muscular disorders. We 
      will review the existing bibliography on the evidence of the efficacy of ESWT for 
      MPS, paying particular attention to MTP (Myofascial Trigger Point) and 
      Fibromyalgia (FM).
CI  - Copyright (c) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All 
      rights reserved.
FAU - Ramon, Silvia
AU  - Ramon S
AD  - Hospital Quiron Barcelona, School of Medicine and Health Sciences, Universitat 
      Internacional de Catalunya. Garcia Cugat Foundation, CEU - UCH Chair of Medicine 
      and Regenerative Surgery, Spain. Electronic address: sramon@comb.cat.
FAU - Gleitz, Markus
AU  - Gleitz M
AD  - Orthopaedic Practice, Luxembourg.
FAU - Hernandez, Leonor
AU  - Hernandez L
AD  - Physical Medicine and Rehabilitation Department, Hospital Quiron Barcelona, 
      Spain.
FAU - Romero, Luis David
AU  - Romero LD
AD  - Physical Medicine and Rehabilitation Department, Hospital Quiron Barcelona, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150910
PL  - United States
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
MH  - Fibromyalgia/*therapy
MH  - High-Energy Shock Waves/*therapeutic use
MH  - Humans
MH  - Myofascial Pain Syndromes/*therapy
OTO - NOTNLM
OT  - Efficacy
OT  - Fibromyalgia
OT  - Myofascial pain
OT  - Shockwave
OT  - Tender point
OT  - Trigger point
EDAT- 2015/09/13 06:00
MHDA- 2016/08/05 06:00
CRDT- 2015/09/13 06:00
PHST- 2015/06/13 00:00 [received]
PHST- 2015/07/31 00:00 [revised]
PHST- 2015/08/06 00:00 [accepted]
PHST- 2015/09/13 06:00 [entrez]
PHST- 2015/09/13 06:00 [pubmed]
PHST- 2016/08/05 06:00 [medline]
AID - S1743-9191(15)01195-4 [pii]
AID - 10.1016/j.ijsu.2015.08.083 [doi]
PST - ppublish
SO  - Int J Surg. 2015 Dec;24(Pt B):201-6. doi: 10.1016/j.ijsu.2015.08.083. Epub 2015 
      Sep 10.